Does “food as medicine” make a big dent in diabetes?
Study of rigorous trial shows mixed results, suggests need to keep examining how nutrition can combat a pervasive disease.
Study of rigorous trial shows mixed results, suggests need to keep examining how nutrition can combat a pervasive disease.
Swallowing the device before a meal could create a sense of fullness, tricking the brain into thinking it’s time to stop eating.
Master’s students Irene Terpstra ’23 and Rujul Gandhi ’22 use language to design new integrated circuits and make it understandable to robots.
A cheaper water desalination device, a wearable ultrasound scanner, and a new kind of supercapacitor were some of MIT News’ most popular articles.
MIT community members made headlines with key research advances and their efforts to tackle pressing challenges.
These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.
This new method draws on 200-year-old geometric foundations to give artists control over the appearance of animated characters.
By reevaluating existing data, researchers find the procedure is even more valuable than consensus had indicated.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
“Minimum viewing time” benchmark gauges image recognition complexity for AI systems by measuring the time needed for accurate human identification.
Using generative AI, MIT chemical engineers and chemists created a model that can predict the structures formed when a chemical reaction reaches its point of no return.
Study shows computational models trained to perform auditory tasks display an internal organization similar to that of the human auditory cortex.
A new method enables optical devices that more closely match their design specifications, boosting accuracy and efficiency.
In a study that could help fill some holes in quantum theory, the team recreated a “quantum bomb tester” in a classical droplet test.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.